Eva Brandén

Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11

Linnéa La Fleur, Elin Falk-Sörqvist, Patrik Smeds et al. · Lung Cancer · 2019 · 223 citations · Full text

Medicine, Genetics, Oncology +17

Patient's and doctors’ delays in the diagnosis of chest tumors

Hirsh Koyi, Gunnar Hillerdal, Eva Brandén · Lung Cancer · 2002 · 134 citations

Medicine, Internal Medicine, Oncology +12

Profiling cancer testis antigens in non–small-cell lung cancer

Dijana Djureinovic, Björn M. Hallström, Masafumi Horie et al. · JCI Insight · 2016 · 124 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Expression of scavenger receptor <scp>MARCO</scp> defines a targetable tumor‐associated macrophage subset in non‐small cell lung cancer

Linnéa La Fleur, Vanessa F. Boura, Andrey Alexeyenko et al. · International Journal of Cancer · 2018 · 95 citations · Full text

Medicine, Immunology, Oncology +17

Prognostic Impact of Tumor Cell Programmed Death Ligand 1 Expression and Immune Cell Infiltration in NSCLC

Karolina Edlund, Katrin Madjar, Johanna Sofia Margareta Mattsson et al. · Journal of Thoracic Oncology · 2019 · 83 citations · Full text

Life Sciences, Immunology, Oncology +17